Anest. intenziv. Med. 2020;31(3):136-137 | DOI: 10.36290/aim.2020.030

Rezistence na diuretikaClinical physiology

Astapenko D.1, Černý V.1-5
1 Klinika anesteziologie, resuscitace a intenzivní medicíny, Univerzita Karlova v Praze, Lékařská fakulta v Hradci Králové, Fakultní nemocnice Hradec Králové
2 Centrum pro výzkum a vývoj, Fakultní nemocnice Hradec Králové
3 Klinika anesteziologie, perioperační a intenzivní medicíny, Univerzita J. E. Purkyně v Ústí nad Labem, Masarykova nemocnice v Ústí nad Labem
4 Department of Anesthesia, Pain Management and Perioperative Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
5 Technická univerzita v Liberci

Published: July 7, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Astapenko D, Černý V. Rezistence na diuretika. Anest. intenziv. Med. 2020;31(3):136-137. doi: 10.36290/aim.2020.030.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Cox ZL, Lenihan DJ. Loop diuretic resistance in heart failure: Resistance etiology‑based strategies to restoring diuretic efficacy. J Card Fail 2014; 20: 611-622. Go to original source... Go to PubMed...
    2. Shah N, Madanieh R, Alkan M, Dogar MU, Kosmas CE, Vittorio TJ. A perspective on diuretic resistance in chronic congestive heart failure. Ther Adv Cardiovasc Dis 2017; 11: 271-278. Go to original source... Go to PubMed...
    3. De Bruyne LKM. Mechanisms and management of diuretic resistance in congestive heart failure. Postgrad Med J 2003; 79: 268-271. Go to original source... Go to PubMed...
    4. Brater DC. Resistance to Loop Diuretics: Why it Happens and What to Do About It. Drugs 1985; 30: 427-443. Go to original source... Go to PubMed...
    5. Koopmans PP, Thien T, Gribnau FWJ. Influence of non‑steroidal anti‑inflammatory drugs on diuretic treatment of mild to moderate essential hypertension. Br Med J 1984; 289: 1492-1494. Go to original source... Go to PubMed...
    6. Loon NR, Wilcox CS, Unwin RJ. Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int 1989; 36: 682-689. Go to original source... Go to PubMed...
    7. Cody RJ, Kubo SH, Pickworth KK. Diuretic treatment for the sodium retention of congestive heart failure. Arch Intern Med 1994; 154: 1905-1914. Go to original source...
    8. Aronson D. The complexity of diuretic resistance. Eur J Heart Fail 2017; 19: 1023-1026. Go to original source... Go to PubMed...
    9. Wargo KA, Banta WM. A comprehensive review of the loop diuretics: Should furosemide be first line? Ann Pharmacother 2009; 43: 1836-1847. Go to original source... Go to PubMed...
    10. Bowman BN, Nawarskas JJ, Anderson JR. Treating Diuretic Resistance: An Overview. Cardiol Rev 2016; 24: 256-260. Go to original source... Go to PubMed...
    11. Santos J, Planas R, Pardo A, Durández R, Cabré E, Morillas RM, et al. Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety. J Hepatol 2003; 39: 187-192. Go to original source... Go to PubMed...
    12. Verbrugge HF, Dupont M, Bertrand BP, Nijst P, Penders J, Dens J, et al. Determinants and impact of the natriuretic response to diuretic therapy in heart failure with reduced ejection fraction and volume overload. Acta Cardiol 2015; 70: 265-273. Go to original source... Go to PubMed...
    13. Elkayam U, Ng TMH, Hatamizadeh P, Janmohamed M, Mehra A. Renal vasodilatory action of dopamine in patients with heart failure: Magnitude of effect and site of action. Circulation 2008; 117: 200-205. Go to original source... Go to PubMed...
    14. Triposkiadis FK, Butler J, Karayannis G, Starling RC, Filippatos G, Wolski K, et al. Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: The Dopamine in Acute Decompensated Heart Failure II (DAD‑HF II) Trial. Int J Cardiol 2014; 172: 115-121. Go to original source... Go to PubMed...
    15. De Vecchis R, Esposito C, Ariano C, Cantatrione S. Besseres renales Sicherheitsprofil und klinische Ergebnisse durch hypertone Kochsalzlösung plus Furosemid i.v. bei akuter dekompensierter Herzinsuffizienz: Eine Metaanalyse der Literatur. Herz 2015; 40: 423-435. Go to original source... Go to PubMed...

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.